Jefferies upgraded Brighthouse Financial to Buy from Hold with a price target of $54, up from $49. The analyst stays constructive on U.S. life insurance and upgrades Brighthouse ahead of the Q2 results. The company is well positioned due to its strong market share in registered index-linked annuities while the stock trades near its lowest absolute and relative multiples since its 2017 separation from MetLife, the analyst tells investors in a research note. The firm now feels Brighthouse offers an attractive risk/reward.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHF:
- Brighthouse Financial price target raised to $59 from $58 at JPMorgan
- Brighthouse Financial price target raised to $49 from $46 at Jefferies
- Brighthouse Financial price target lowered to $45 from $50 at Piper Sandler
- Brighthouse Financial upgraded to Market Perform at Keefe Bruyette
- Brighthouse Financial’s Governance and Compensation Wins Approval